DNA Medicine

Basel, Switzerland, September 13, 2026 Roche announced that its collaborator MediLink Therapeutics has reported positive Phase III clinical trial...

Paris, France and New York, USA, September 14, 2026 Cyllene Therapeutics announced that the U.S. Food and Drug Administration...